Strides Pharma Science consolidated Q3FY22 loss at Rs. 121.67 crores

Strides Pharma Science Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 804.582 crores during the period ended December 31, 2021 as compared to Rs. 743.683 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. -121.671 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -162.559 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. -13.55 for the period ended December 31, 2021 as compared to Rs. -18.12 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 804.582 crs	₹743.683 crs	8.19%
Net Profit	₹-121.671 crs	₹-162.559 crs	25.15%
EPS	₹-13.55	₹-18.12	25.22%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 804.582 crores during the period ended December 31, 2021 as compared to Rs.845.225 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-121.671 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.37.847 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.-13.55 for the period ended December 31, 2021 as compared to Rs.4.22 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 804.582 crs	₹845.225 crs	-4.81%
Net Profit	₹-121.671 crs	₹37.847 crs	-421.48%
EPS	₹-13.55	₹4.22	-421.09%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.2250.163 crores during the 9 Months period ended December 31, 2021 as compared to Rs.2445.756 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.-489.430 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.222.356 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.-54.54 for the 9 Months period ended December 31, 2021 as compared to Rs.24.79 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹2250.163 crs	₹2445.756 crs	-8.00%
Net Profit	₹-489.430 crs	₹222.356 crs	-320.11%
EPS	₹-54.54	₹24.79	-320.01%

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 395.10 as compared to the previous close of Rs. 393.75. The total number of shares traded during the day was 13102 in over 413 trades.

The stock hit an intraday high of Rs. 399.00 and intraday low of 390.40. The net turnover during the day was Rs. 5169146.00.

Source : Equity Bulls

Keywords

StridesPharmaScience Q3FY22 9MFY22 ResultUpdate